Trial Profile
Follow-up of Thyroid Cancer Patients From Study THYR-008-00 Who Received Thyroid Remnant Ablation Using Either the Hypothyroid or the Thyrogen Method.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Aug 2013
Price :
$35
*
At a glance
- Drugs Thyrotropin alfa (Primary)
- Indications Thyroid cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Genzyme Corporation
- 19 Aug 2009 New trial record